Register to track cancer immune therapy and side effects
Part of Cancer clinical trials.
This study sets up a real-world patient database to follow people starting cancer immunotherapy and record immune-related side effects. You may help doctors better understand who gets these side effects and how they change over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 or older
- Be starting cancer immunotherapy (like PD-1/PD-L1/CTLA-4 and similar), or have restarted it at least 6 months after your last immunotherapy
- Have received written information about the study and agree to participate
- If you join for blood/samples, consent is required; you must be able to provide required sample eligibility
- Not be pregnant; not refuse participation; and not be under legal protection
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at side effects from immunotherapy in people with solid or blood cancers. It may help doctors better manage these side effects in the future.
This study looks at how people’s bodies respond to cancer immunotherapy and why some people get side effects. Your information and lab results may help improve how immunotherapy is managed in the future.
This study watches immune system markers to see if they can predict which patients will respond well to immunotherapy and who might have side effects. If you have cancer and are starting immunotherapy, this trial may help guide future treatment decisions.
This study asks people with cancer about their experiences when joining an immunotherapy (a cancer treatment that helps the immune system fight cancer) clinical trial. It may help the researchers understand what patients experience during these trials and improve how trials support patients.
This study looks at how immune-related side effects happen in people treated with certain cancer immunotherapies. It also includes some healthy volunteers and people who already have similar autoimmune conditions, to better understand and compare these reactions.
This is an observational study that follows adults with solid cancer who are receiving immune checkpoint inhibitor treatments. It aims to learn how these medicines are used and what outcomes may look like in everyday care.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.